| Erlotinib Hydrochloride studied in …STUDIED_INderived184 of 184show fewer |
|---|
| → studied in | NCT01660971Phase 1 · active not recruiting Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Pancreatic Carcinoma,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01708954Phase 2 · active not recruiting Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm,Pancreatic Neoplasm,Pancreatic Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045201Phase 1 · active not recruiting Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00076310Phase 2 · completed OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02193282Phase 3 · active not recruiting Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04172779Phase 2 · not yet recruiting Erlotinib for Hepatocellular Carcinoma Chemoprevention · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03137771Phase 2 · active not recruiting Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06997068Phase 2 · recruiting Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm,Malignant Lip and Oral Cavity Neoplasm,Malignant Laryngeal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00885066Phase 1 · completed Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013649Phase 3 · completed Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery · 184 trials list this drug (8 active) | — | — | Pancreatic Intraductal Papillary Mucinous Neoplasm,Pancreatic Adenocarcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954226Phase 1 · completed Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Head and Neck Carcinoma,Skin Carcinoma,Salivary Gland Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535338Phase 1/Phase 2 · completed Erlotinib Hydrochloride and Onalespib Lactate in Treating Patients With Recurrent or Metastatic EGFR-Mutant Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720304Phase 2 · completed Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064479Phase 2 · completed Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck · 184 trials list this drug (8 active) | — | — | Laryngeal Squamous Cell Carcinoma,Oral Cavity Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254384Phase 1 · completed Docetaxel, Cisplatin, and Erlotinib Hydrochloride in Treating Patients With Stage I-III Non-small Cell Lung Cancer Following Surgery · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273362Phase 1/Phase 2 · completed Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver · 184 trials list this drug (8 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00079053Phase 1 · completed Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068587Phase 1/Phase 2 · completed MET/VEGFR2 Inhibitor GSK1363089 and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone in Locally Advanced or Metastatic NSCLC That Has Not Responded to Previous Chemotherapy · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02154490completed Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · 184 trials list this drug (8 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02961374Phase 2 · completed Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617708Phase 1/Phase 2 · completed S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01911507Phase 1 · completed INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00376948Phase 2 · completed Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00130728Phase 3 · completed A Study to Evaluate the Efficacy of Bevacizumab in Combination With Tarceva for Advanced Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033514Phase 1/Phase 2 · completed Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01532089Phase 2 · completed Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations · 184 trials list this drug (8 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00950365Phase 2 · completed Pemetrexed Disodium With or Without Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV or Recurrent Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00749892Phase 2 · completed Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer · 184 trials list this drug (8 active) | — | — | Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm,Malignant Ureter Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087035Phase 2 · completed Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer · 184 trials list this drug (8 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088946Phase 2 · completed Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer · 184 trials list this drug (8 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01222689Phase 2 · completed Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857271Phase 2 · terminated Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02169284Phase 2 · terminated Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery · 184 trials list this drug (8 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00313560Phase 2 · completed ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01192815Phase 2 · terminated Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck · 184 trials list this drug (8 active) | — | — | Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma,Oral Cavity Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030446Phase 2 · completed Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 184 trials list this drug (8 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026338Phase 3 · completed Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00436332Phase 2 · completed S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02926638Phase 2/Phase 3 · terminated Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches · 184 trials list this drug (8 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445848Phase 2 · completed S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00661193Phase 2 · completed S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664897Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 184 trials list this drug (8 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Chronic Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00733746Phase 2 · completed Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259089Phase 1/Phase 2 · completed Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126581Phase 2 · completed Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Adenocarcinoma,Lung Adenosquamous Carcinoma,Minimally Invasive Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01866410Phase 2 · completed Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00940316Phase 2 · completed Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00503841NA · terminated Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100854Phase 2 · completed Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00573989Phase 1/Phase 2 · terminated Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688973Phase 2 · completed Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Renal Cell Carcinoma,Type 1 Papillary Renal Cell Carcinoma,Type 2 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00287989Phase 2 · completed Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00390429Phase 1/Phase 2 · completed Docetaxel and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00733408Phase 2 · completed Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00720356Phase 2 · completed Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01592383Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma · 184 trials list this drug (8 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030576Phase 1/Phase 2 · completed Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055913Phase 1/Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Laryngeal Squamous Cell Carcinoma,Salivary Gland Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01103375Phase 1 · terminated Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma · 184 trials list this drug (8 active) | — | — | Adult Mixed Glioma,Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601913early Phase 1 · completed Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335764Phase 1/Phase 2 · completed Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 184 trials list this drug (8 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01561014Phase 1 · completed Oxaliplatin, Fluorouracil, Erlotinib Hydrochloride, and Radiation Therapy Before Surgery and Erlotinib Hydrochloride After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction · 184 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm,Esophageal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085553Phase 1 · completed Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors · 184 trials list this drug (8 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00096265Phase 3 · terminated Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316757Phase 2 · completed Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · 184 trials list this drug (8 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00553462Phase 2 · completed Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365144Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033241Phase 1 · completed Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm,Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00428194Phase 1 · withdrawn Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer · 184 trials list this drug (8 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068367Phase 2 · completed S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor · 184 trials list this drug (8 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01344824Phase 2 · completed Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never Smokers · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00881751Phase 2 · completed Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer · 184 trials list this drug (8 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045110Phase 1/Phase 2 · completed Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma · 184 trials list this drug (8 active) | — | — | Adult Anaplastic Astrocytoma,Adult Anaplastic Oligodendroglioma,Adult Giant Cell Glioblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00086879Phase 2 · completed Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054132Phase 2 · completed Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00987766Phase 1 · completed Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Malignant Gallbladder Neoplasm,Malignant Liver Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00280150Phase 1/Phase 2 · completed Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550537Phase 2 · completed Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00425386Phase 2 · completed Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer · 184 trials list this drug (8 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00283244Phase 2 · completed Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00550836Phase 2 · completed Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00453362Phase 1/Phase 2 · completed A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00854308Phase 2 · completed A Study of MetMAb Administered to Patients With Advanced Non-Small Cell Lung Cancer, in Combination With Tarceva (Erlotinib) · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00499655Phase 2 · completed Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074864Phase 2/Phase 3 · unknown Targeted Treatment With Intercalated Radiotherapy in EGFR-mutant IIIA/IIIB NSCLC · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470535Phase 2 · terminated Erlotinib in Treating Patients With Stage III or Stage IV Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00059852Phase 2 · completed Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · 184 trials list this drug (8 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00975182Phase 1 · completed A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors · 184 trials list this drug (8 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839955Phase 1 · completed Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00281866Phase 2 · completed Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01515969Phase 1 · terminated Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC) · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445588Phase 2 · completed Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme · 184 trials list this drug (8 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Brain Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00257608Phase 3 · completed A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00524121Phase 2 · completed Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer · 184 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054275Phase 2 · completed Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00634725Phase 3 · completed Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00124657Phase 1/Phase 2 · completed Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738881Phase 3 · terminated Pemetrexed Disodium or Erlotinib Hydrochloride as Second-Line Therapy in Treating Patients With Advanced Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00660816Phase 2 · completed Pemetrexed or Docetaxel With or Without Erlotinib in Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134886Phase 1 · terminated Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV Infection · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193881Phase 1 · terminated RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126620Phase 1 · completed Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895128Phase 1 · completed Study of Erlotinib in Combination With Dasatinib · 184 trials list this drug (8 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895687Phase 1 · completed Study of Erlotinib in Combination With Bortezomib · 184 trials list this drug (8 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01928160Phase 2 · withdrawn Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00365391Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer · 184 trials list this drug (8 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093222Phase 2 · completed Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma · 184 trials list this drug (8 active) | — | — | Gallbladder Adenosquamous Carcinoma,Gallbladder Carcinoma,Gallbladder Undifferentiated Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00032110Phase 2 · completed Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Colon Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013831Phase 1 · terminated Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00754494Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma · 184 trials list this drug (8 active) | — | — | Adenomatous Polyp,Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00275132Phase 3 · completed Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276575Phase 1 · completed Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465815Phase 1/Phase 2 · withdrawn Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN) · 184 trials list this drug (8 active) | — | — | Malignant Skin Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482625Phase 2 · terminated Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Intraductal Papillary Mucinous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00088959Phase 1 · completed Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101348Phase 1/Phase 2 · completed Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Malignant Salivary Gland Neoplasm,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049283Phase 1 · completed Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Laryngeal Squamous Cell Carcinoma,Laryngeal Verrucous Carcinoma,Malignant Tongue Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00976677Phase 2 · terminated Carboplatin, Paclitaxel, and Bevacizumab With or Without Erlotinib Hydrochloride in Treating Non-Smokers With Advanced Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00356889Phase 2 · completed Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors · 184 trials list this drug (8 active) | — | — | Malignant Digestive System Neoplasm,Malignant Gallbladder Neoplasm,Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00778167Phase 1/Phase 2 · completed Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00091026Phase 2 · completed Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126542Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer · 184 trials list this drug (8 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00353301Phase 2 · completed Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma · 184 trials list this drug (8 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193154Phase 2 · completed OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma · 184 trials list this drug (8 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00085280NA · completed Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030485Phase 2 · completed Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer · 184 trials list this drug (8 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045487Phase 2 · completed Erlotinib in Treating Patients With Advanced Kidney Cancer · 184 trials list this drug (8 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00054496Phase 2 · unknown Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00278187Phase 2 · unknown Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055770Phase 1/Phase 2 · completed Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Malignant Salivary Gland Neoplasm,Laryngeal Squamous Cell Carcinoma,Salivary Gland Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049166Phase 1 · completed Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer · 184 trials list this drug (8 active) | — | — | Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060411Phase 1 · completed A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Colon Mucinous Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00072072Phase 1 · completed Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00360854Phase 1 · unknown Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566800Phase 1 · unknown Erlotinib in Treating Patients With Barrett Esophagus · 184 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00385398Phase 2 · withdrawn QOL-Stereotactic RadioSurgery, Temozolomide + Erlotinib-Rx of 1-3 Brain Metastases in NSCLC · 184 trials list this drug (8 active) | — | — | Malignant Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00263822Phase 3 · completed Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer · 184 trials list this drug (8 active) | — | — | Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00989690Phase 3 · unknown Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039494Phase 2 · completed Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors · 184 trials list this drug (8 active) | — | — | Adult Giant Cell Glioblastoma,Adult Glioblastoma,Adult Gliosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00955695Phase 3 · unknown Radiation Therapy to the Brain or Observation in Preventing Brain Metastases in Patients With Advanced Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00466687Phase 2 · completed Erlotinib and Bevacizumab in Treating Patients With Stage IV Melanoma · 184 trials list this drug (8 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00032123Phase 2 · completed Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer · 184 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049101Phase 1/Phase 2 · completed Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030537Phase 2 · completed Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062101Phase 2 · completed Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087269Phase 2 · terminated Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00077454Phase 1 · completed Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors · 184 trials list this drug (8 active) | — | — | Childhood Malignant Germ Cell Tumor,Osteosarcoma,Childhood Medulloblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00033462Phase 2 · completed Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer · 184 trials list this drug (8 active) | — | — | Malignant Gallbladder Neoplasm,Adult Hepatocellular Carcinoma,Malignant Extrahepatic Bile Duct Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045526Phase 2 · completed Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer · 184 trials list this drug (8 active) | — | — | Malignant Esophageal Neoplasm,Esophageal Squamous Cell Carcinoma,Esophageal Adenocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063947Phase 1 · completed Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387894Phase 2 · terminated Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma · 184 trials list this drug (8 active) | — | — | Adult Brain Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01013506Phase 2 · withdrawn Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast Cancer · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00410826Phase 2 · completed Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer · 184 trials list this drug (8 active) | — | — | Laryngeal Squamous Cell Carcinoma,Hypopharyngeal Squamous Cell Carcinoma,Oropharyngeal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416650Phase 2 · completed Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00060307Phase 2 · completed Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer · 184 trials list this drug (8 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087412Phase 2 · completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · 184 trials list this drug (8 active) | — | — | Lung Large Cell Carcinoma,Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039182Phase 2 · completed Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung · 184 trials list this drug (8 active) | — | — | Malignant Mesothelioma,Pleural Solitary Fibrous Tumor,Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042809Phase 1 · completed Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047333Phase 2 · terminated Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed · 184 trials list this drug (8 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00047346Phase 1 · completed Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction · 184 trials list this drug (8 active) | — | — | Adult Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031993Phase 2 · completed Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix · 184 trials list this drug (8 active) | — | — | Cervical Squamous Cell Carcinoma,Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030498Phase 1 · completed Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm,Malignant Breast Neoplasm,Malignant Mesothelioma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00063895Phase 1/Phase 2 · completed Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck · 184 trials list this drug (8 active) | — | — | Lung Non-Small Cell Carcinoma,Ovarian Carcinoma,Laryngeal Squamous Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00274833Phase 2 · completed Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme · 184 trials list this drug (8 active) | — | — | Adult Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00738335Phase 1 · withdrawn Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases · 184 trials list this drug (8 active) | — | — | Malignant Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00293436Phase 1/Phase 2 · withdrawn Celecoxib and Erlotinib in Treating Patients With Liver Cancer · 184 trials list this drug (8 active) | — | — | Malignant Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00633750Phase 2 · completed Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118261Phase 1 · completed Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer · 184 trials list this drug (8 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00611715Phase 2 · terminated Ph II Letrozole + OSI-774 (Tarceva) in Post-menopausal, w/ ER and/or PR-positive Met Breast Cancer. · 184 trials list this drug (8 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00320073Phase 1 · completed Vinflunine and Erlotinib or Pemetrexed in Treating Patients With Unresectable or Metastatic Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00266097Phase 1 · completed Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Malignant Gallbladder Neoplasm,Malignant Extrahepatic Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227032Phase 1 · terminated Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme · 184 trials list this drug (8 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00554775Phase 2 · terminated WBRT & Erlotinib in Advanced NSCLC and Brain Metastases · 184 trials list this drug (8 active) | — | — | Malignant Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00217529Phase 1/Phase 2 · completed Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer · 184 trials list this drug (8 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673569Phase 2 · completed Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387322Phase 1/Phase 2 · completed Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors · 184 trials list this drug (8 active) | — | — | Adult Solid Neoplasm,Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00125021Phase 2 · completed Tarceva and Capecitabine for Pancreatic Cancer · 184 trials list this drug (8 active) | — | — | Malignant Pancreatic Neoplasm,Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00801385Phase 2 · unknown Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy · 184 trials list this drug (8 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |